Ionis Pharmaceuticals | IONS - Srodki Pieniężne I Ekwiwalent





Srodki Pieniężne I Ekwiwalent Zmiana Data
Agios Pharmaceuticals USD 99.65M 13.95M 2026-06
Alnylam Pharmaceuticals USD 1.71B 2.46M 2026-06
Arrowhead Research USD 19.68M 127.85M 2026-06
Astellas Pharma JPY 281.6B 93.23B 2026-03
BioCryst Pharmaceuticals USD 154.97M 16.62M 2026-06
BioMarin Pharmaceutical USD 874M 1.35B 2026-06
Celltrion KRW 56.79B 6.92B 2026-03
Cspc Pharmaceutical CNY 6.09B 1.48B 2025-12
Deva Holding AS TRY 775.92M 574.67M 2023-09
Divis Laboratories Ltd INR 1.28B 2.87B 2026-03
Exelixis USD 281.45M 55.3M 2026-06
Halozyme Therapeutics USD 163.14M 146.61M 2026-06
Ionis Pharmaceuticals USD 350.06M 1.57B 2026-06
Kangmei Pharma CNY 1.23B 48.16M 2026-03
Knight Therapeutics CAD 76.45M 5.43M 2025-12
Laboratorios Farma EUR 46.11M 18.92M 2025-06
Malin Corporation EUR 62.1M 26.4M 2024-12
Medical Developments International AUD 17.84M 219K 2025-06
Moderna USD 1.72B 185M 2026-06
Nektar Therapeutics USD 149.58M 134.46M 2026-03
Neuren Pharmaceuticals AUD 4.23M 1.68M 2025-12
Neurocrine Biosciences USD 332.4M 65.9M 2026-06
Novartis USD 7.62B 739M 2026-06
Omeros USD 1.9M 2.36M 2025-06
OPKO Health USD 341.88M 27.22M 2026-03
Organigram Holdings CAD 4.29M 3.28M 2026-03
Pfizer USD 976M 727M 2026-06
Pharma Mar EUR 19.34M 29.53M 2026-06
PTC Therapeutics USD 1.05B 215.9M 2026-06
Qiagen NV USD 646.29M 192.72M 2026-03
Regeneron Pharmaceuticals USD 2.46B 506.8M 2026-06
Roche Holding CHF 7.55B 579M 2025-06
Sarepta Therapeutics USD 571.15M 106.7M 2026-06
Sartorius EUR 291M 282.8M 2026-06
Sino Biopharmaceutical CNY 3.38B 2.09B 2024-12
Tilray USD 264.83M 43.16M 2025-06
Ultragenyx Pharmaceutical USD 125M 50M 2026-06
Vertex Pharmaceuticals USD 7.85B 605.7M 2026-06
Zealand Pharma A/S 3.85B 727.54M 2026-03
Zz Pientze Pharmaceu CNY 1.96B 186.63M 2026-03